The sixteen-year-old decided it was time to change. She was tired of being bullied for her size and had been told (repeatedly by her parents, her doctors, and a whole bunch of trolls online) she would be so much healthier if she lost weight. She started a glucagon-like peptide-1 (GLP-1) medication, and her appetite disappeared, as did her weight. At every visit, the adults around her celebrated. For the first time she could remember, she was told she was doing something right.
Then her dose was lowered to slow the weight loss. Her hunger came back, and so did some of the weight, and with it came something new: panic. Eating terrified her. Through all the praise, no one had asked how she felt about food or her body.
I have practiced pediatrics for twenty-two years, and I believe GLP-1 medications are a valuable tool. I have also seen how easily an eating disorder can hide inside praise and the feeling of finally being in control.
Eating disorders in kids are common, and they are serious. In a study of 2022 national survey data published this year by the Centers for Disease Control and Prevention (CDC), caregivers reported that nearly one in three children and teens ages 6 to 17, about 15 million kids, had engaged in at least one disordered eating behavior in the past year. In a network of 12 children’s hospitals, adolescent hospitalizations for eating disorders rose more than sevenfold from 2010 to 2021. Anorexia carries nearly six times the expected risk of death, and about one in five of those deaths is a suicide.
Real physician voices, twice a week
Free, and one click to unsubscribe.
For decades, we have called childhood obesity an epidemic and measured progress by pounds lost. Kids in larger bodies hear that message at school, at the dinner table, and in the exam room. The American Academy of Pediatrics and The Obesity Society have warned that weight stigma contributes to binge eating, social isolation, avoidance of health care, and more weight gain. When success is defined as weight loss, we rarely ask what is going on behind the weight: the teasing, the shame, the eating a child has learned to hide. One teen told me during a sports physical, “I’ll lose weight when I want to.” In one sentence, she named what weight bias feels like from the inside, and how much energy it takes to keep pushing back against a world that tells her, again and again, that her body is the problem.
Now add a medication that works by making it easy to eat less. Dieting and weight loss are well-established risk factors for eating disorders. The American Academy of Pediatrics warns that some teens develop an eating disorder while trying to lose weight, and that it can be missed when clinicians focus only on the weight loss. In one study of adolescent dieters, more than half had escalated to fasting, skipping meals, or other disordered restriction five years later.
Which brings me to SURMOUNT-ADOLESCENTS, the Eli Lilly-sponsored trial of tirzepatide (Mounjaro, Zepbound) in 160 teenagers, published in JAMA on Nov. 15. Lilly helped design the study, analyze the data, and write the paper. Teens on the drug lowered their body mass index (BMI) by about 18.5 percent over 72 weeks.
The trial did not screen for eating disorders. No validated eating disorder screener was used before or during treatment, in a study whose primary measure of success was weight loss.
Read closely, the supplement holds one teen’s story in a single line of a safety table: A participant in the placebo group was hospitalized “due to excessive weight loss,” “related to anorexic eating disorders.” That teen received no medication, only the diet and activity counseling every participant got. A study that does not actively ask about kids’ relationship with food and body will find an eating disorder only after a child is hospitalized.
In the drug group, one teen had serious events including “excessive weight loss,” “loss of appetite,” and dehydration, which resolved “without interruption of study treatment.” Half of the teens on tirzepatide vomited. No one measured what was happening to their relationship with food.
A kid who skips lunch and gets praised at the next weigh-in may be restricting in plain sight. In the CDC study, restrictive eating was more common among children whose doctor had told a parent the child was overweight. When a drug suppresses appetite, restriction can pass for compliance, and the praise that follows can feed it.
The trial did measure well-being, with a questionnaire (the Impact of Weight on Quality of Life-Kids) in which every item begins “Because of my weight.” It is no surprise that body esteem rose as weight fell. The tool never assessed how a teen could feel at home in the body they already had. Psychological care for body image works on exactly that question, and in one randomized trial, a brief cognitive-behavioral program reduced body dissatisfaction for months, regardless of body mass.
The fix is within reach. A 2026 expert consensus in World Psychiatry recommended assessing every patient for current or past eating disorders before starting a GLP-1, and monitoring during treatment. As guidance from the National Eating Disorders Association notes, atypical anorexia, which occurs in people who are not underweight, is more likely to go undiagnosed.
I challenge clinicians and researchers alike to screen for eating disorders before these medications start, and to keep asking all the way through. The American Academy of Pediatrics already recommends routine eating disorder screening at annual checkups. Brief validated screeners such as the SCOFF and the Eating Disorder Screen for Primary Care take only minutes. At every visit, ask how a child feels about food, hunger, and their body, and listen to the answer. Require eating disorder measures in every pediatric GLP-1 trial. And stop treating weight loss as the only proof that progress is happening.
GLP-1 medications can help many kids, but if the scale is the only thing we measure, we will keep missing the eating disorders hiding in plain sight.
Wendy Schofer is a physician board-certified in pediatrics and lifestyle medicine and a passionate advocate for trauma-informed relational health and eating disorder prevention. She is the founder of Family in Focus, a size-inclusive, relational health practice focused on eating disorder prevention, where she helps families build the social-emotional skills that strengthen relationships with food, body, and especially each other.
She holds professional coaching credentials through the International Coaching Federation as a Professional Certified Coach with a Mentor Coaching Specialization, and she is recognized as a National Board Certified Health and Wellbeing Coach. She is an assistant professor of community pediatrics at Virginia Health Sciences at Old Dominion University and an adjunct instructor in the Human Capital Management Department of the School of Professional Studies at New York University.
She hosts the podcast Family in Focus with Wendy Schofer, MD and shares updates on Instagram, Facebook, TikTok, and YouTube.
Your KevinMD author page is one of the top results for your name. Turn it into a premium profile, publish in 1 to 3 days, and get a guaranteed podcast slot.



